0001209191-17-007335.txt : 20170202 0001209191-17-007335.hdr.sgml : 20170202 20170202201209 ACCESSION NUMBER: 0001209191-17-007335 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170131 FILED AS OF DATE: 20170202 DATE AS OF CHANGE: 20170202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Versartis, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4200 BOHANNON DRIVE STREET 2: SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6509638580 MAIL ADDRESS: STREET 1: 4200 BOHANNON DRIVE STREET 2: SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shepard Jay CENTRAL INDEX KEY: 0001587788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 17570016 MAIL ADDRESS: STREET 1: 15977 GRANDVIEW AVENUE CITY: MONTE SERENO STATE: CA ZIP: 95030 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-31 0 0001513818 Versartis, Inc. VSAR 0001587788 Shepard Jay C/O VERSARTIS, INC. 4200 BOHANNON DRIVE, SUITE 250 MENLO PARK CA 94025 1 1 0 0 President and CEO Common Stock 2017-01-31 4 M 0 10662 2.53 A 234046 D Common Stock 2017-01-31 4 S 0 4722 13.40 D 229324 D Common Stock 2017-01-31 4 S 0 5940 14.16 D 223384 D Common Stock 2017-02-01 4 M 0 6576 2.53 A 229960 D Common Stock 2017-02-01 4 S 0 6576 13.95 D 223384 D Common Stock 2017-02-02 4 M 0 4166 2.53 A 227550 D Common Stock 2017-02-02 4 S 0 6973 13.51 D 220577 D Stock Option (Right to Buy) 2.53 2017-01-31 4 M 0 10662 0.00 D 2023-12-27 Common Stock 10662 97736 D Stock Option (Right to Buy) 2.53 2017-02-01 4 M 0 6576 0.00 D 2023-12-27 Common Stock 6576 91160 D Stock Option (Right to Buy) 2.53 2017-02-01 4 M 0 4166 0.00 D 2023-12-27 Common Stock 4166 86994 D Shares sold pursuant to 10b5-1 plan. The shares were sold at prices ranging from $12.70 to $13.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $13.70 to $14.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $13.70 to $14.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $13.30 to $13.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Kevin Haas, Attorney-in-fact 2017-02-02